Literature DB >> 24173497

Potential of [18F]-fluoromisonidazole positron-emission tomography for radiotherapy planning in head and neck squamous cell carcinomas.

B Henriques de Figueiredo1, T Merlin, H de Clermont-Gallerande, M Hatt, D Vimont, P Fernandez, F Lamare.   

Abstract

BACKGROUND AND
PURPOSE: Positron-emission tomography (PET) with [(18)F]-fluoromisonidazole (FMISO) permits consideration of radiotherapy dose escalation to hypoxic volumes in head and neck cancers (HNC). However, the definition of FMISO volumes remains problematic. The aims of this study are to confirm that delayed acquisition at 4 h is most appropriate for FMISO-PET imaging and to assess different methods of volume segmentation. PATIENTS AND METHODS: A total of 15 HNC patients underwent several FMISO-PET/computed tomography (CT) acquisitions 2, 3 and 4 h after FMISO injection. Three automatic methods of PET image segmentation were tested: fixed threshold, adaptive threshold based on the ratio between tumour-derived and background activities (R(T/B)) and the fuzzy locally adaptive Bayesian (FLAB) method. The hypoxic fraction (HF), which is defined as the ratio between the FMISO and CT volumes, was also calculated.
RESULTS: The R(T/B) for images acquired at 2, 3 and 4 h differed significantly, with mean values of 2.5 (1.7-2.9), 3 (2-4.5) and 3.4 (2.3-6.1), respectively. The mean tumour volume, as defined manually using CT images, was 39.1 ml (1.2-116 ml). After 4 h, the mean FMISO volumes were 18.9 (0.1-81), 9.5 (0.9-33.1) and 12.5 ml (0.9-38.4 ml) with fixed threshold, adaptive threshold and the FLAB method, respectively; median HF values were 0.47 (0.1-1.93), 0.25 (0.11-0.75) and 0.35 (0.14-1.05), respectively. FMISO volumes were significantly different.
CONCLUSION: The best contrast is obtained at the 4-hour acquisition time. Large discrepancies were found between the three tested methods of volume segmentation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173497     DOI: 10.1007/s00066-013-0454-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  19 in total

1.  A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET.

Authors:  Mathieu Hatt; Catherine Cheze le Rest; Alexandre Turzo; Christian Roux; Dimitris Visvikis
Journal:  IEEE Trans Med Imaging       Date:  2009-01-13       Impact factor: 10.048

2.  Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

Authors:  Piet Dirix; Vincent Vandecaveye; Frederik De Keyzer; Sigrid Stroobants; Robert Hermans; Sandra Nuyts
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

3.  Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer.

Authors:  Daniel Zips; Klaus Zöphel; Nasreddin Abolmaali; Rosalind Perrin; Andrij Abramyuk; Robert Haase; Steffen Appold; Jörg Steinbach; Jörg Kotzerke; Michael Baumann
Journal:  Radiother Oncol       Date:  2012-09-27       Impact factor: 6.280

4.  PET-guided dose escalation tomotherapy in malignant pleural mesothelioma.

Authors:  Andrei Fodor; Claudio Fiorino; Italo Dell'Oca; Sara Broggi; Marcella Pasetti; Giovanni Mauro Cattaneo; Luigi Gianolli; Riccardo Calandrino; Nadia Gisella Di Muzio
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

5.  Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers.

Authors: 
Journal:  Semin Radiat Oncol       Date:  1996-01       Impact factor: 5.934

6.  Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?

Authors:  N Abolmaali; R Haase; A Koch; D Zips; J Steinbach; M Baumann; J Kotzerke; K Zöphel
Journal:  Nuklearmedizin       Date:  2010-12-17       Impact factor: 1.379

7.  Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.

Authors:  Richard A Popple; Roger Ove; Sui Shen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-01       Impact factor: 7.038

8.  Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance.

Authors:  Kristi Hendrickson; Mark Phillips; Wade Smith; Lanell Peterson; Kenneth Krohn; Joseph Rajendran
Journal:  Radiother Oncol       Date:  2011-08-27       Impact factor: 6.280

9.  High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.

Authors:  Shozo Okamoto; Tohru Shiga; Koichi Yasuda; Yoichi M Ito; Keiichi Magota; Katsuhiko Kasai; Yuji Kuge; Hiroki Shirato; Nagara Tamaki
Journal:  J Nucl Med       Date:  2013-01-15       Impact factor: 10.057

10.  Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.

Authors:  Susanne Martina Eschmann; Frank Paulsen; Claudia Bedeshem; Hans-Jürgen Machulla; Thomas Hehr; Michael Bamberg; Roland Bares
Journal:  Radiother Oncol       Date:  2007-05-31       Impact factor: 6.280

View more
  7 in total

Review 1.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

Review 2.  A review on segmentation of positron emission tomography images.

Authors:  Brent Foster; Ulas Bagci; Awais Mansoor; Ziyue Xu; Daniel J Mollura
Journal:  Comput Biol Med       Date:  2014-04-28       Impact factor: 4.589

Review 3.  Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.

Authors:  Sonja Stieb; Afroditi Eleftheriou; Geoffrey Warnock; Matthias Guckenberger; Oliver Riesterer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-20       Impact factor: 9.236

Review 4.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with intensity-modulated radiotherapy in head-and-neck cancers.

Authors:  B Henriques de Figueiredo; C Zacharatou; S Galland-Girodet; J Benech; H De Clermont-Gallerande; F Lamare; M Hatt; L Digue; E De Mones del Pujol; P Fernandez
Journal:  Strahlenther Onkol       Date:  2014-09-23       Impact factor: 3.621

6.  The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.

Authors:  Shozo Okamoto; Tohru Shiga; Koichi Yasuda; Shiro Watanabe; Kenji Hirata; Ken-Ichi Nishijima; Keiichi Magota; Katsuhiko Kasai; Rikiya Onimaru; Kazuhiko Tuchiya; Yuji Kuge; Hiroki Shirato; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-01       Impact factor: 9.236

Review 7.  Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings.

Authors:  Florence Colliez; Bernard Gallez; Bénédicte F Jordan
Journal:  Front Oncol       Date:  2017-01-25       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.